Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy

The major objection to the use of retroperitoneal lymphadenectomy in low-stage testis cancer has been the universal loss of ejaculatory ability if a full bilateral dissection is performed. The Indiana University experience with nerve-sparing dissection is presented. One hundred percent of the patients subjected to this procedure maintain ejaculatory ability.